Edition:
United States

Biostar Pharmaceuticals Inc (BSPM.OQ)

BSPM.OQ on NASDAQ Stock Exchange Capital Market

2.82USD
4:00pm EDT
Change (% chg)

$-0.21 (-6.93%)
Prev Close
$3.03
Open
$3.01
Day's High
$3.01
Day's Low
$2.80
Volume
4,343
Avg. Vol
136,158
52-wk High
$5.96
52-wk Low
$1.18

Chart for

About

Biostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops,... (more)
No analyst recommendations are available for .

Overall

Beta: 1.83
Market Cap(Mil.): $4.05
Shares Outstanding(Mil.): 2.66
Dividend: --
Yield (%): --

Financials

  BSPM.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -2.89 -- --
ROI: -15.20 1.58 14.38
ROE: -15.20 2.41 16.07

BRIEF-Biostar Pharmaceuticals Files For Non-Timely 10-K With U.S. SEC

* BIOSTAR PHARMACEUTICALS FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2JfTgd0) Further company coverage:

Apr 02 2018

BRIEF-Biostar Pharmaceuticals Announces Plans To Launch A New Ecommerce Sales Platform

* BIOSTAR PHARMACEUTICALS, INC. ANNOUNCES PLANS TO LAUNCH A NEW ECOMMERCE SALES PLATFORM Source text for Eikon: Further company coverage:

Feb 21 2018

BRIEF-Biostar Says Shaanxi Aoxing Renewed GMP Certification

* SHAANXI AOXING PHARMACEUTICAL CO., LTD. RENEWED ITS GMP CERTIFICATION

Feb 07 2018

BRIEF-Biostar Regains Compliance With Nasdaq Continued Listing Requirement

* BIOSTAR REGAINS COMPLIANCE WITH NASDAQ CONTINUED LISTING REQUIREMENT Source text for Eikon: Further company coverage:

Dec 04 2017

BRIEF-Biostar Pharma qtrly ‍loss per share $0.05

* Biostar Pharmaceuticals Inc. announces its quarterly results for nine months ended September 30, 2017

Nov 20 2017

BRIEF-Biostar Pharmaceuticals qtrly loss per share $‍0.50​

* Biostar Pharmaceuticals, Inc. announces its quarterly results for three months ended June 30, 2017

Nov 15 2017

Earnings vs. Estimates